Skip to main content

Table 4 Survival analysis

From: Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer

Breed

Age (years)

Clinical stage (TNM)

Survival at ten months

Observations

Standard scheme (Dox)

Standard Poodle

12

III

Yes

Alive without relapse

Maltese bichon

9

III

No

Death, surgical complications

Dachshund

13

III

Yes

Alive without relapse

Maltese bichon

7

III

No

Death, surgical complications

Standard scheme (Dox + I2)

Rottweiler

8

III

Yes

Alive with relapse; no metastasis

Standard Poodle

12

II

Yes

Alive without relapse

Standard Poodle

10

III

Yes

Alive with relapse; no metastasis

Labrador Retriever

10

III

Yes

Alive without relapse

Standard Poodle

12

V

Yes

Alive without relapse

Standard Poodle

9

III

Yes

Alive without relapse

Modified scheme (Dox)

Cocker Spaniel

9

II

No

Death, transitional cell cancer

Mixed breed

6

II

No

Euthanasia, suspected metastasis

Cocker Spaniel

8

I

Yes

Alive without relapse

Chihuahua

5

I

Yes

Alive without relapse

German Shepherd

7

III

No

Death, anaplastic cancer

Dalmatian

6

I

Yes

Alive without relapse

Modified scheme (Dox + I2)

Cocker Spaniel

10

III

Yes

Alive without relapse

Mixed breed

8

I

Yes

Alive without relapse

Standard Poodle

11

V

No

Death, extensive metastasis

Cocker Spaniel

13

III

Yes

Alive without relapse

Fox terrier Toy

7

I

Yes

Alive without relapse

Standard Poodle

10

III

Yes

Alive without relapse

Cocker Spaniel

13

III

No

Death, pyometra

Standard Poodle

10

II

Yes

Alive without relapse

Standard Poodle

9

III

Yes

Alive without relapse

Chihuahua

5

III

Yes

Alive without relapse

Dachshund

10

III

No

Death, surgical complications